Ticagrelor addition to heparin not tied to improved outcomes in COVID-19: JAMA Medha Baranwal1 March 2022 9:00 AM ISTUSA: The use of a P2Y12 inhibitor in addition to a therapeutic dose of heparin versus heparin alone does not improve survival free of organ support in...
Submit revised protocol for Ticagrelor SR tablets: CDSCO panel tells MSN Labs Susmita Roy15 Feb 2022 5:44 PM ISTNew Delhi: Opining that the Phase III clinical trial protocol presented by the drug maker MSN Laboratories was inadequate with respect to...
Study Finds New Evidence on Personalized Selection of Antiplatelet Therapy MD Bureau3 Feb 2022 9:00 AM ISTOral P2Y12 inhibitors (clopidogrel, prasugrel, and ticagrelor) used in conjunction with aspirin constitute a key strategy for the prevention of...
Ticagrelor doesn't improve acute coronary syndrome compared to Prasugrel: Study MD Editorial Team27 Jan 2022 8:30 AM ISTDelhi: A meta-analysis by Fong L.C.W. and team revealed that ticagrelor did not reduce the primary composite endpoint of myocardial infection (MI),...
Efficacy and safety of ticagrelor versus prasugrel not affected by eGFR in ACS patients: ISAR-REACT 5 trial Medha Baranwal12 Jan 2022 9:00 AM ISTGermany: Results from ISAR-REACT 5 trial have shown that a reduction of estimated glomerular filtration rate (eGFR) is related to increased risk for...
Bentracimab effectively reduces antiplatelet effects of ticagrelor: REVERSE-IT Medha Baranwal10 Dec 2021 9:00 AM ISTUSA: Patients undergoing surgery and those with major bleeding when given Bentracimab (PhaseBio), an intravenous reversal agent for ticagrelor,...
Bentracimab safe to reverse Ticagrelor's effects Dr. Nandita Mohan1 Dec 2021 5:33 PM ISTBentracimab, an intravenous reversal agent for ticagrelor, has shown immediate and sustained reversal of the Tiacgrelor's antiplatelet effects in both...
Ticagrelor can be discontinued 2-3 days prior to CABG without increasing Bleeding Risk Dr. Nandita Mohan30 Nov 2021 2:25 PM ISTAccording to new randomized data, in patients with ACS, performing CABG within a couple of days after ticagrelor cessation is noninferior to waiting 5...
Medical Bulletin 27/November/2021 Dr. Nandita Mohan27 Nov 2021 7:15 PM ISTHere are Top Medical stories of the daySelf-management BP tool in SmartphonesA new study conducted by Tomer Gazit and team showed that a mobile...
AHA 2021: Bentracimab rapid and safe to reverse Ticagrelor's effects, REVERSE IT study. dr. Abhimanyu Uppal24 Nov 2021 11:00 AM ISTBentracimab, an intravenous reversal agent for ticagrelor, has shown immediate and sustained reversal of the Tiacgrelor's antiplatelet effects in both...
CABG 2-3 days after ticagrelor cessation is safe: RAPID CABG trial Medha Baranwal20 Nov 2021 11:15 AM ISTUSA: A small, randomized study of people who had heart attacks demonstrated no increased risk of bleeding when ticagrelor was stopped 2-3 days before...
Indian Pharmacopoeia Commission flags adverse reactions linked to Rosuvastatin, Baclofen, others Medical Dialogues Team16 July 2021 2:49 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC) has issued drug safety alerts, revealing that certain drugs, such as Clobazam, Baclofen, and...
